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 3 
Introduction 
Our program is designed to gain qualitative information about the characteristics and risk 
factors associated with the Intimate Partner Violence (IPV) among the Chinese immigrants who 
reside in the Raleigh/Cary metropolitan area in North Carolina.  IPV is the threat or use of 
violence or intimidation by an intimate partner to gain and maintain power and control over 
another person (Interact, 2009).  IPV comes in many different forms, including physical abuse, 
sexual abuse, emotional abuse, economic abuse, isolation and intimidation.  Many abusers 
engage in more than one type of abuse, and the boundaries between some of these types of abuse 
often overlap (Center for Disease Control and Prevention [CDC], 2009; Interact, 2009). 
IPV can affect health in many ways.  Many victims suffer physical injuries.  Some are 
minor, such as cuts, scratches, bruises, and welts.  Others are more serious and can cause lasting 
disabilities.  These include broken bones, internal bleeding, and head trauma.  IPV can also cause 
emotional harm. Victims often have low self-esteem and they may have a hard time trusting 
others and having successful relationships.  The anger and stress experienced by victims may 
lead to eating disorders and depression.  Some victims contemplate or commit suicide.  IPV is 
linked to harmful health behaviors as well.  Victims are more likely to smoke, abuse alcohol, use 
drugs, and engage in risky sexual activity (CDC, 2009). 
IPV occurs in all countries, all cultures and at every level of society without exception 
(Krug, Dahlberg, Mercy, Zwi, & Lozaro, eds., 2002).  Although women can be violent towards 
their male partners and violence also occurs between partners of the same sex, the overwhelming 
burden of partner violence is borne by women at the hands of men.  In 48 population-based 
surveys from around the world, 10-69% of women reported being physically assaulted by a male 
intimate partner at some point in their lives (Krug et al., 2002).  Although poverty and associated 
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stress, patriarchy, depression, and substance use/abuse have all been associated with IPV, the 
causes for IPV are complex and understanding the causes of such violence requires research in 
many social contexts (Jewkes, 2002; Riggs & Street, DS, 2000).  Cross-cultural research 
suggests that societies with stronger ideologies of male dominance have more IPV (Jewkes, 
2002).  These ideologies affect individual behaviors and also have an impact at many levels 
within a society.  At a societal level they affect female autonomy, access to political systems, and 
influence in the economy.  Such ideologies also affect laws and criminal justice systems.  For 
example, whether violence against women is considered a crime and treated with seriousness by 
law enforcers. 
As with the causes of IPV, the strategies for intervention and prevention of IPV are also 
complex and need to be developed from a socio-ecological perspective.  Female empowerment 
has been shown to be protective against IPV.  For example, a study by Parker et al. (Parker, 
McFarlene, Soeken, Silva, & Reel, 1999) demonstrated that intervention using empowerment as 
the framework significantly reduced the incidence of IPV.  Empowerment interventions include 
(a) protection—a focus on increasing the woman’s safety and (b) enhanced choice-making and 
problem-solving in decisions about the relationship, relocation, and other transitional issues.  At 
the individual level, this model emphasizes that the woman, as the victim of IPV, can make 
decisions and collaborate with others to solve her dilemma, thus allowing the woman to express 
her feelings to a nonjudgmental and empathetic person, and make her own decisions about the 
future. 
Female empowerment can also be derived from interpersonal, community, and 
institutional sources such as social/community support, education, and legislative action.  
Education confers empowerment via social networks, self-confidence, and an ability to use 
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information and resources available in society.  Multiple studies have indicated that high 
educational achievement by women is associated with low levels of violence (Jewkes R, 2002; 
Thompson et al., 2006; Maziak, 2002, Lancet).  The following is a brief list of IPV intervention 
and prevention strategies based on the Socio-Ecological Model (SEM): 
At the social/community level: 
 Address gender issues, violence, and non-violent conflict resolution in school and 
community programs 
 Support community activities and campaigns in the media to increase awareness of 
violence against women 
 Positive role modeling of women in the media 
At the institute level:  
 Establish comprehensive legislation on gender equality, IPV, and sexual 
violence/harassment  
 Train and monitor the police and criminal justice system to ensure that legislation is 
satisfactorily enforced  
 Improve opportunities for women’s employment and access to credit 
IPV is a serious social and public health problem which causes physical injuries and 
psychological harm to the victims.  In the United States, IPV was first identified as a national 
problem four decades ago by feminist movement (Kilpatrick, 2004), and has since gained 
increasing interest in its intervention and prevention.  However, studies on IPV in Asian 
American population or its ethnic subgroups have been scarce.  The purpose of our program is to 
obtain qualitative, culture-related IPV data from the Chinese immigrants who reside in the 
Raleigh/Cary metropolitan area in North Carolina.  Not only will this information provide us a 
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preliminary description of the nature of IPV in this community, more importantly, it could guide 
us to form hypotheses and develop programs which will increase the awareness and promote the 
prevention of IPV among this population. 
 
Study Design and Methods 
In traditional Chinese families, family structure is hierarchical and patriarchal, which 
legitimizes men’s control of women.   Even though China has little notion of individual privacy, 
violence against a woman by her husband is generally concealed and protected within the sphere 
of private life and is largely overlooked and ignored (Xu et al., 2005).  The few studies that have 
been conducted found that 20-30% of Chinese women have been physically abused by their 
spouses (Xu et al., 2005;  Parish, Wang, Laumann, Pan, & Luo,  2004).  However, it is difficult 
to estimate the prevalence of IPV in China because the Chinese have different definitions of 
abuse (Midlarsky, Venkataramani-Kothari, & Plante, 2006), and generally do not consider 
psychological and verbal ill-treatment as abusive. For example, if a Chinese woman is belittled 
by her husband, her earnings are taken from her and she is locked in the house when she is not at 
work, her community will not view her husband’s behavior as abusive (Midlarsky et al., 2006). 
 There are approximately 2.4 million ethnic Chinese living in the United States (US 
Census Bureau, 2010).  Chinese Americans constitute the largest portion of the Asian American 
population, comprising more than 23% of the group.  The size of the Chinese American 
population today is probably underestimated in the official census data due to the number of new 
immigrants who prefer to remain undocumented for legal, financial, and other reasons.  As in 
most immigrant groups, Chinese immigrants experience great individual, cultural, and family 
stress in the process of transition and acculturation (Leong, 2001), which plays a role in IPV.  A 
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good example is that Chinese immigrant couples find themselves in a new culture that has 
different gender role expectations than their culture of origin, which can cause changes in the 
power balance in couples (Jin & Keat, 2010).   
Chinese society is typically more patriarchal than American society, and Chinese men 
tend to enjoy a power imbalance in their favor in marriages (Chan & Leong, 1994).  In the 
United States, Chinese men may find their traditional position within the couple challenged (Jin 
& Keat, 2010).  Language problems or a different professional structure in the U.S. may restrict a 
husband’s employment options, while the cultural expectation that he provide for his family may 
remain the same.  At the same time, wives who played a less prominent role outside the home in 
China may become an indispensable part of the workforce in the U.S., so their individual 
socioeconomic power could rise post-immigration.  Women’s relatively low socioeconomic 
status in their homelands may make it easier for them to cope in the new country because they 
are less likely to experience a relatively unskilled job as a loss or denigration.  Social support in 
the U.S. for more equality within couples may also shift the female role to one of greater power 
post-immigration (Liao, 2006), which further upsets the balance in the family and increases the 
likelihood of IPV. 
We chose the Chinese in the Raleigh/Cary area as the target population for our study 
because this is a fast growing area with a steady inflow of immigrants.  According to the U. S. 
Census Bureau, Raleigh/Cary saw its population climb 4.3% between July 1, 2007, and July 1, 
2008, to 1.1 million, which makes it the nation’s fastest-growing metro area between 2007 and 
2008 (U. S. Census Bureau, 2010). There are estimated six thousand Chinese in the 
Raleigh/Cary, NC (Cary, North Carolina, 2010; Raleigh, North Carolina, 2010) area, and we will 
recruit study participants through the following avenues: 
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 Through collaboration with the Triangle Area Chinese American Society (TACAS): 
TACAS is a non-political, non-profit organization, and is one of the biggest and most 
established Chinese organizations in the Research Triangle area which covers Raleigh 
and Cary.  TACAS was founded in 1979 with the missions of fostering the Chinese-
American cultural exchange, promote Chinese language and cultural education, and 
participate in public welfare and community services. TACAS is dedicated to community 
services and co-organizes Asian American Health Fair, Immigration seminar, and provide 
resources to charity and local activities.  We will distribute flyers during TACAS events; 
advertise on the TACAS Newsletters and website, http://www.nctacas.org/. 
 Pamphlets and flyers will be given at the Grand Asia Market (GAM) located in Cary, 
North Carolina.  GAM is the biggest Chinese Grocer in the Triangle area and is the major 
store for the local Chinese to get Asian groceries; it has also been utilized by various 
community groups to distribute information about their activities and services.  With all 
the foot traffic in GAM, we believe we should be able to promote our program and 
generate interest for participation. 
The inclusion criteria for study participants include: Chinese immigrants, female, 18 
years of age or older, English-speaking, married or having been in a relationship with a man.  
Our goal is to form at least two focus groups with six participants per group.  A focus group is a 
form of qualitative research in which a group of people are asked about their perceptions, 
opinions, beliefs and attitudes towards a product, service, concept, advertisement, idea, or 
packaging (Focus group, 2010).  Focus groups provide the opportunity to gain information in a 
semi-structured group discussion format, and have become an increasingly common research 
method.  Focus groups do not follow a rigid question-and-answer format.  Instead, questions are 
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identified by the group facilitator and are used to begin the process and to move the discussion 
along.  For the most part, the specific content addressed, the order of the content, and the 
specificity provided is determined by the group’s participants.  Such methods are extremely 
useful in exploratory work where an investigator is not testing specific hypotheses or making 
precise measurements of a phenomenon but is trying to learn more about a previously 
understudied topic.  Also, group members discover a common language to describe similar 
experiences, and this enables the capture of a form of “native language” to understand the 
situation (Focus group, 2010). 
Focus groups in our program will be facilitated by Huei-Chen Lao, under the guidance of 
Mrs. Ritu Kaur, the Associate Director of Community Relations at Interact of Wake County.  
Interact is “a private, non-profit, United Way agency that provides safety, support, and 
awareness to victims and survivors of domestic violence and rape/sexual assault.  Interact also 
promotes violence-free relationships and communities through collaboration, public information, 
education and advocacy.” (http://www.interactofwake.org/).   
Huei-Chen Lao has been a volunteer for Interact Speakers’ Bureau since 2008 and she 
has given presentations to various groups and local organizations.  She has also facilitated 
children’s groups.  Huei-Chen will prepare questionnaires and have them reviewed by Mrs. Kaur 
before focus groups start.  Questions that are focused on three themes will be presented to the 
participants to elicit discussion: (1) Perceptions about IPV—How does each participant perceive 
and understand IPV as an individual and where does this understanding come from?  (2) What 
are the influences of specific elements of culture regarding IPV?  Discuss the cultural and 
religious practices, family rituals, gender roles, and the functions of individuals and groups 
related to IPV. (3) What is the awareness of and access to agencies that intervene and provide 
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services to IPV victims and survivors, such as Interact, that participants have?  A display for 
Interact will be set up for the focus groups and it includes the information about the confidential 
and free services provided by Interact such as 24 hour Crisis-Lines, Youth Education Services, 
Counseling, Residential Shelter, and Rape prevention Education.   
 
Ethical Concerns 
 It is very important that we are familiar with the specific ethical issues raised by work 
that involves IPV.  A World Health organization (WHO) report, Putting Women First: Ethical 
and Safety Recommendations for Research on Domestic Violence against Women (Putting 
Women First, 2001), highlights the need for specific precautions in undertaking such research—
“Research on violence against women raises important ethical and methodological challenges in 
addition to those posed by any research. The nature of the topic means that issues of safety, 
confidentiality and interviewer skill and training are even more important than for other areas of 
research. It is not an exaggeration to say that the physical safety and psychological well-being of 
both the respondents and the research team can be put in jeopardy if adequate precautions are not 
taken.” (Putting Women First, 2001) 
 We will abide by the guidance given in this report to guard the study participants from 
any harm.  For example, a number of mechanisms are recommended to protect the 
confidentiality of the information collected, including: 
 No names should be written on questionnaires.  Instead, unique codes should be used to 
distinguish questionnaires.  Where identifiers are needed to link a questionnaire with the 
household location or respondent, they should be kept separately from the questionnaires, 
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and upon completion of the research, destroyed.  Participants should be informed of 
confidentiality procedures as part of the consent process. 
 Where tapes are made of in-depth interviews with survivors of violence, these should be 
kept in a locked cabinet with limited access, and erased following transcription.  The 
permission of the respondents should be sought before taping. 
 Particular care should be taken during the presentation of the research findings that the 
information presented is sufficiently aggregated to ensure that no one community or 
individual can be identified.  Where case-study findings are presented, sufficient detail 
should be changed to ensure that it is not possible to identify the source of this 
information. 
This report also provides guidelines to reduce any possible distress caused to participants 
by the research.  Domestic violence is a sensitive and stigmatized issue, and women are often 
blamed for the violence they experience.  Therefore all questions about violence and its 
consequences should be asked in a supportive and non-judgmental manner.  In addition, some 
women may become emotional during a discussion or an interview, and interviewers need to be 
trained to be aware of the effects that the questions may have on the informant and how best to 
respond, based on the woman’s level of distress.  All interviews should end in a positive manner 
and interviewer training needs to include practice on how to terminate an interview if the impact 
of the questions becomes too negative. 
In addition, an application for the Institutional Review Board (IRB) Approval of Human 
Subjects Research will be sent to the Office of Human Research Ethics at University of North 
Carolina at Chapel Hill.  The purpose of the IRB review is to assure that appropriate steps are 
taken to protect the rights and welfare of human participants as subjects in a research study.  
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Research protocols and related materials such as informed consent documents will be submitted 
to the review committee to ensure protection of the rights and welfare of human subjects of 
research.  
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APPENDIX A 
 
 
OFFICE OF HUMAN RESEARCH ETHICS 
Institutional Review Board 
 
APPLICATION FOR IRB APPROVAL OF 
HUMAN SUBJECTS RESEARCH 
Version June 25, 2009 
  
 
Part A.1.  Contact Information, Agreements, and Signatures 
 
Date:  April 1, 2010 
 
Title of Study:  Intimate Partner Violence Prevention Project with the 
Raleigh/Cary Chinese Community 
 
Name and degrees of Principal Investigator:  Huei-Chen Lao, MS, MPH Candidate 
Department:  Public Health Leadership Mailing address/CB #:        
UNC-CH PID:  713417036       Pager:        
Phone #:  (919) 541-3418     Fax #:        Email Address:  lao1@niehs.nih.gov 
 
For trainee-led projects: __ undergraduate  _X_ graduate  __ postdoc  __ resident  __ other 
Name of faculty advisor:  William Williamson 
Department:  Public Health Leadership Mailing address/CB #:  4111 McGavran-
Greenberg Hall, CB#7469 
Phone #:  (919) 966-5285 Fax #:        Email Address:  wwilliam@email.unc.edu 
 
Center, institute, or department in which research is based if other than department(s) 
listed above:  InterAct Family Safety & Empowerment Center (InterAct) 
 
Name of Project Manager or Study Coordinator (if any):       
Department:        Mailing address/CB #:        
Phone #:        Fax #:        Email Address:        
 
List all other project personnel including co-investigators, and anyone else who has contact 
with subjects or identifiable data from subjects.  Include name, location (UNC or specific 
outside location), role and email address for each person who should receive electronic 
copies of IRB correspondence to PI. 
Ritu Kaur, Associate Director of Community Relations, InterAct 
rituk@interactofwake.org 
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Name of funding source or sponsor (please do not abbreviate):        
__  not funded   __  Federal   __  State   __  industry   __  foundation   __  UNC-CH 
_X_  other (specify):  InterAct 
 
For external funding, RAMSeS proposal number (from Office of Sponsored Research): 
      
 
For industry sponsored research (if applicable): 
Sponsor’s master protocol version #:       Version date:       
Investigator Brochure version #:       Version date:       
Any other details you need documented on IRB approval:       
 
 
Checklist of Items to Include with Your Submission 
 
Include the following items with your submission, where applicable. 
 Check the relevant items below and include one copy of all checked items 1-11 in the order 
listed. 
 Also include two additional collated sets of copies (sorted in the order listed) for items 1-6. 
 
Applications must “stand alone” and should provide all information requested, i.e., 
complete answers must be contained in the application.  While you may reference other 
documents with supporting information, do not respond solely by stating “see attached.” 
 
Applications will be returned if these instructions are not followed. 
 
Check Item 
Total No. of 
Copies 
□ 1.  This application.  One copy must have original PI signatures. 3 
□ 
2.  Consent and assent forms (include DHHS-approved sample, when one 
exists), fact or information sheets, phone and verbal consent scripts. 
3 
□ 3.  HIPAA authorization addendum to consent form. 3 
□ 
4.  All recruitment materials including final copies of printed advertisements, 
audio/video taped advertisements, scripts, flyers, letters, and emails. 
3 
□ 
5.  Questionnaires, focus group guides, scripts used to guide phone or in-
person interviews, etc. 
3 
□ 
6.  Documentation of reviews from any other committees (e.g., Clinical and 
Translational Research Center (CTRC), Oncology Protocol Review 
Committee, or local review committees in Academic Affairs). 
3 
□ 
7.  Protocol, grant application or proposal supporting this submission, if any 
(e.g., extramural grant application to NIH or foundation, industry 
protocol, student proposal).  This must be submitted if an external 
funding source or sponsor is checked on the previous page. 
1 
□ 
8.  Addendum for Multi-Site Studies where UNC-CH is the Lead 
Coordinating Center. 
1 
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□ 
9.  Data use agreements (may be required for use of existing data from third 
parties). 
1 
□ 
10.  Only for those study personnel not in the online UNC-CH human 
research ethics training database 
(http://cfx3.research.unc.edu/training_comp/):  Documentation of 
required training in human research ethics. 
1 
□ 
11.  For drug studies, Investigator Brochure if one exists.  If none, include 
package insert for previously approved uses.. 
1 
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Principal Investigator:  I will personally conduct or supervise this research study.  I will ensure 
that this study is performed in compliance with all applicable laws, regulations and University 
policies regarding human subjects research.  I will obtain IRB approval before making any 
changes or additions to the project.  I will notify the IRB of any other changes in the information 
provided in this application.  I will provide progress reports to the IRB at least annually, or as 
requested.  I will report promptly to the IRB all unanticipated problems or serious adverse events 
involving risk to human subjects.  I will follow the IRB approved consent process for all 
subjects.  I will ensure that all collaborators, students and employees assisting in this research 
study are informed about these obligations.  All information given in this form is accurate and 
complete.  
 
    
Signature of Principal Investigator Date 
 
Faculty Advisor if PI is a Student or Trainee Investigator:  I accept ultimate responsibility for 
ensuring that this study complies with all the obligations listed above for the PI. 
 
    
Signature of Faculty Advisor Date 
 
 
 
Note: The following signature is not required for applications with a student PI. 
 
Department or Division Chair, Center Director (or counterpart) of PI:  (or Vice-Chair or 
Chair’s designee if Chair is investigator or otherwise unable to review):  I certify that this 
research is appropriate for this Principal Investigator, that the investigators are qualified to 
conduct the research, and that there are adequate resources (including financial, support and 
facilities) available.  If my unit has a local review committee for pre-IRB review, this 
requirement has been satisfied.  I support this application, and hereby submit it for further 
review. 
 
    
Signature of Department Chair or designee Date 
 
    
Print Name of Department Chair or designee Department 
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Part A.2.  Summary Checklist  Are the following involved?  Yes No 
A.2.1.  Existing data, research records, patient records, and/or human biological specimens?   __   _X_ 
A.2.2.  Surveys, questionnaires, interviews, or focus groups with subjects?   _X_   __ 
A.2.3.  Videotaping, audiotaping, filming of subjects, or analysis of existing tapes?   __   _X_ 
A.2.4.  Do you have specific plans to enroll subjects from these vulnerable or select populations: 
a.  UNC-CH students or UNC-CH employees? 
b.  Non-English-speaking? 
c.  Decisionally impaired? 
d.  Patients? 
e.  Prisoners, others involuntarily detained or incarcerated, or parolees? 
f.  Pregnant women? 
g.  Minors (less than 18 years)?  If yes, give age range:       to       years   
 
  __ 
  __ 
  __ 
  __ 
  __ 
  __ 
  __ 
 
  _X_ 
  _X_ 
  _X_ 
  _X_ 
  _X_ 
  _X_ 
  __ 
A.2.5.  a.  Are sites outside UNC-CH engaged in the research? 
b.  Is UNC-CH the sponsor or lead coordinating center for a multi-site study? 
If yes, include the Addendum for Multi-site Studies. 
If yes, will any of these sites be outside the United States? 
If yes, is there a local ethics review committee agency with jurisdiction? (provide contact 
information) 
  _X_ 
  __ 
 
  __ 
  __ 
 
  __ 
  _X_ 
 
  __ 
  __ 
 
A.2.6.  Will this study use a data and safety monitoring board or committee? 
 If yes: UNC-CH NC TraCS DSMB? (must apply separately) 
 Lineberger Cancer Center DSMC? 
 Other?  Specify:        
  __ 
  __ 
  __ 
  __ 
  _X_ 
  __ 
  __ 
  __ 
A.2.7.  a.  Are you collecting sensitive information such as sexual behavior, HIV status, recreational 
drug use, illegal behaviors, child/physical abuse, immigration status, etc? 
b.  Do you plan to obtain a federal Certificate of Confidentiality for this study? 
c.  Is this research classified (e.g., requires security clearance)? 
  __ 
  __ 
  __ 
  _X_ 
  _X_ 
  _X_ 
A.2.8.  a.  Investigational drugs? (provide IND #      ) 
b.  Approved drugs for “non-FDA-approved” conditions? 
All studies testing substances in humans must provide a letter of acknowledgement from the UNC 
Health Care Investigational Drug Service (IDS). 
  __ 
  __ 
  _X_ 
  _X_ 
A.2.9.  Placebo(s)?   __   _X_ 
A.2.10.  Investigational devices, instruments, machines, software?  (provide IDE #      )   __   _X_ 
A.2.11.  Fetal tissue?   __   _X_ 
A.2.12.  Genetic studies on subjects’ specimens?   __   _X 
A.2.13.  Storage of subjects’ specimens for future research? 
 If yes, see instructions for Consent for Stored Samples.  
  __   _X_ 
A.2.14.  Diagnostic or therapeutic ionizing radiation, or radioactive isotopes, which subjects would 
not receive otherwise? 
 If yes, approval by the UNC-CH Radiation Safety Committee is required. 
  __ 
   
  _X_ 
   
A.2.15.  Recombinant DNA or gene transfer to human subjects? 
 If yes, approval by the UNC-CH Institutional Biosafety Committee is required. 
  __   _X_ 
A.2.16.  Does this study involve UNC-CH cancer patients? 
 If yes, submit this application directly to the Oncology Protocol Review Committee. 
  __   _X_ 
A.2.17.  Will subjects be studied in the Clinical and Translational Research Center (CTRC) or is the 
CTRC involved in any other way with this study?  If yes, obtain the CTRC Addendum and 
submit completed application (IRB application and Addendum) directly to the CTRC.  The CTRC 
includes facilities located on the 3
rd
 floor of the Main Hospital (formerly GCRC) and Ground 
floor Burnett-Womack (formerly CCCT). 
  __   _X_ 
A.2.18.  Will gadolinium be administered as a contrast agent? ..__ .._X_ 
A.2.19.  Will subjects’ Social Security Number (SSN) be collected for:   
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              a. processing payments greater than $200 per year, to support IRS reporting (see also B.6)? 
              b. processing payments of any amount through UNC-CH Accounts Payable? 
              c. use as a unique identifier for study tracking purposes for national registry or database? 
 
  __ 
  __ 
  __ 
  _X_ 
  _X_ 
  _X_ 
 
Part A.3.  Conflict of Interest Questions and Certification 
 
The following questions apply to all investigators and study staff engaged in the design, 
conduct, or reporting results of this project and/or their immediate family members.  For these 
purposes, "family" includes the individual’s spouse and dependent children.  “Spouse” includes a 
person with whom one lives together in the same residence and with whom one shares 
responsibility for each other’s welfare and shares financial obligations. 
A.3.1.  Currently or during the term of this research study, does any member of the research 
team or his/her family member have or expect to have: 
(a) A personal financial interest in or personal financial relationship (including gifts of cash 
or in-kind) with the sponsor of this study? 
(b) A personal financial interest in or personal financial relationship (including gifts of cash 
or in-kind) with an entity that owns or has the right to commercialize a product, process or 
technology studied in this project? 
(c) A personal financial interest in or personal financial relationship (including gifts of cash 
or in-kind) with an entity engaged in the performance of this project as a subcontractor, sub-
recipient or vendor? 
(d) A board membership of any kind or an executive position (paid or unpaid) with the 
sponsor of this study or with an entity that owns or has the right to commercialize a product, 
process or technology studied in this project? 
 
 
__  yes 
 
__  yes 
 
__  yes 
 
__  yes 
 
 
_X_  no 
 
_X_  no 
 
_X_  no 
 
_X_  no 
A.3.2.  Has the University or has a University-related foundation received a cash or in-kind gift 
from the sponsor of this study for the use or benefit of any member of the research team? 
 
__  yes 
 
_X_  no 
A.3.3.  Has the University or has a University-related foundation received a cash or in-kind gift 
for the use or benefit of any member of the research team from an entity that owns or has the 
right to commercialize a product, process or technology studied in this project? 
 
__  yes 
 
_X_  no 
 
If the answer to ANY of the questions above is yes, the affected research team member(s) must 
complete and submit the form, which is accessible online at http://coi.unc.edu.  List name(s) of 
all research team members for whom any answer to the questions above is yes:  
  
 
Certification by Principal Investigator:  By submitting this IRB application, I (the PI) 
certify that the information provided above is true and accurate regarding my own 
circumstances, that I have inquired of every UNC-Chapel Hill employee or trainee who will 
be engaged in the design, conduct or reporting of results of this project as to the questions 
set out above, and that I have instructed any such person who has answered “yes” to any of 
these questions to complete and submit for approval a Conflict of Interest Evaluation 
Form.  I understand that as Principal Investigator I am obligated to ensure that any 
potential conflicts of interest that exist in relation to my study are reported as required by 
University policy. 
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Signature of Principal Investigator Date 
 
Faculty Advisor if PI is a Student or Trainee Investigator:  I accept ultimate responsibility 
for ensuring that the PI complies with the University’s conflict of interest policies and 
procedures. 
 
    
Signature of Faculty Advisor Date 
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Part A.4.  Questions Common to All Studies 
 
For all questions, if the study involves only secondary data analysis, focus on your proposed 
design, methods and procedures, and not those of the original study that produced the data you 
plan to use. 
 
Complete answers must be provided.  While you may reference other documents with supporting 
information, do not respond solely by stating “see attached.” 
 
A.4.1.  Brief Summary.  Provide a brief non-technical description of the study, which will be 
used in IRB documentation as a description of the study.  Typical summaries are 50-100 words.  
Please reply to each item below, retaining the subheading labels already in place, so that 
reviewers can readily identify the content. 
 
Purpose:  The Intimate Partner Violence (IPV) Prevention Project with the Raleigh/Cary Chinese 
is designed to gain qualitative information about the characteristics and risk factors 
associated with the Intimate Partner Violence (IPV) among the Chinese immigrants who 
reside in the Raleigh/Cary metropolitan area in North Carolina. 
Participants:  Female Chinese immigrants who reside in Raleigh/Cary metropolitan area, 18 
years of age or older, married or having been in a relationship with a man.  Staff members 
from InterAct, Triangle Area Chinese American Society (TACAS), and Grand Asia Market 
in Cary. 
Procedures (methods):  Focus groups with six participants per group will be formed and 
discussions will be conducted among group members to gain information about their 
perceptions, opinions, beliefs and attitudes about IPV.  Study participant demographics, 
group discussion records, activity logs, and other records will be kept by investigators for 
analysis. 
  
A.4.2.  Purpose and Rationale.  Provide a summary of the background information, state the 
research question(s), and tell why the study is needed.  If a complete rationale and literature 
review are in an accompanying grant application or other type of proposal, only provide a brief 
summary here.  If there is no proposal, provide a more extensive rationale and literature review, 
including references. 
IPV is a serious social and public health problem which causes physical injuries and 
psychological harm to the victims.  In the United States, IPV was first identified as a national 
problem four decades ago by feminist movement (Kilpatrick, 2004), and has since gained 
increasing interest in its intervention and prevention.  However, studies on IPV in Asian 
American population or its ethnic subgroups have been scarce.  The purpose of our program is to 
obtain qualitative, culture-related IPV data from the Chinese immigrants who reside in the 
Raleigh/Cary metropolitan area in North Carolina.  Not only will this information provide us a 
preliminary description of the nature of IPV in this community, more importantly, it could guide 
us to form hypotheses and develop programs which will increase the awareness and promote the 
prevention of IPV among this population. 
Focus group discussions will be focused on three themes: (1) Perceptions about IPV—
How does each participant perceive and understand IPV as an individual and where does this 
understanding come from.  (2) Influence of specific elements of culture regarding IPV; discuss 
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the cultural and religious practices, family rituals, gender roles, and the functions of individuals 
and groups related to IPV. (3) Participants’ awareness and access to agencies that intervene and 
provide services to IPV victims and survivors, such as Interact.   
 
A.4.3.  Subjects.  You should describe the subject population even if your study does not involve 
direct interaction (e.g., existing records).  Specify number, gender, ethnicity, race, and age.  
Specify whether subjects are healthy volunteers or patients.  If patients, specify any relevant 
disease or condition and indicate how potential subjects will be identified.  Researchers are 
reminded that additional approvals may be needed from relevant “gatekeepers” to access subjects 
(e.g., school principals, facility directors, hospital or healthcare system administrators). 
            
  The subject population is female Chinese immigrants who reside in the Raleigh/Cary, 
North Carolina. The participants will be 18 years of age or older, English-speaking, married or 
having been in a relationship with a man.  We would like to recruit twelve participants and 
divide them into two focus groups. All participants will be healthy volunteers. 
 
A.4.4.  Inclusion/exclusion criteria.  List required characteristics of potential subjects, and 
those that preclude enrollment or involvement of subjects or their data.  Justify exclusion of any 
group, especially by criteria based on gender, ethnicity, race, or age.  If pregnant women are 
excluded, or if women who become pregnant are withdrawn, specific justification must be 
provided. 
             
 We have identified our target population as describes above.  Men will be excluded from 
the study, as the overwhelming burden of partner violence is borne by women at the hands of 
men.  Moreover, our limited resource also necessitates a narrowing of the target population.  
Only Chinese will be included in this study because the purpose of this study is to obtain 
qualitative, culture-related IPV data which could guide us to form hypotheses and develop 
programs that will increase the awareness and promote the prevention of IPV among this 
population.   
 
A.4.5.  Full description of the study design, methods and procedures.  Describe the research 
study.  Discuss the study design; study procedures; sequential description of what subjects will 
be asked to do; assignment of subjects to various arms of the study if applicable; doses; 
frequency and route of administration of medication and other medical treatment if applicable; 
how data are to be collected (questionnaire, interview, focus group or specific procedure such as 
physical examination, venipuncture, etc.).  Include information on who will collect data, who 
will conduct procedures or measurements.  Indicate the number and duration of contacts with 
each subject; outcome measurements; and follow-up procedures.  If the study involves medical 
treatment, distinguish standard care procedures from those that are research.  If the study is a 
clinical trial involving patients as subjects and use of placebo control is involved, provide 
justification for the use of placebo controls.   
 
Twelve study participants will be divided into two groups.  Focus groups in our program 
will be facilitated by Huei-Chen Lao, under the guidance of Mrs. Ritu Kaur, the Associate 
Director of Community Relations at Interact of Wake County.  Interact is “a private, non-profit, 
United Way agency that provides safety, support, and awareness to victims and survivors of 
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domestic violence and rape/sexual assault.  Interact also promotes violence-free relationships and 
communities through collaboration, public information, education and advocacy.” 
(http://www.interactofwake.org/).   
Huei-Chen will prepare questionnaires and have them reviewed by Mrs. Kaur before 
focus groups start.  Questions that are focused on three themes will be presented to the 
participants to elicit discussion: (1) Perceptions about IPV—How does each participant perceive 
and understand IPV as an individual and where does this understanding come from.  (2) 
Influence of specific elements of culture regarding IPV; discuss the cultural and religious 
practices, family rituals, gender roles, and the functions of individuals and groups related to IPV. 
(3) Participants’ awareness and access to agencies that intervene and provide services to IPV 
victims and survivors, such as Interact.  Responses to the questions will be recorded and 
collected by Huei-Chen, reviewed and analyzed by her and Ms. Kaur.  Huei-Chen is bilingual in 
Chinese and English and her background of being from the same cultural heritage should help 
her establish relationship with the focus group participants. In addition, a display for Interact will 
be set up for the focus groups and it includes the information about the confidential and free 
services provided by Interact such as 24 hour Crisis-Lines, Youth Education Services, 
Counseling, Residential Shelter, and Rape prevention Education.   
 
A.4.6.  Benefits to subjects and/or society.  Describe any potential for direct benefit to 
individual subjects, as well as the benefit to society based on scientific knowledge to be gained; 
these should be clearly distinguished.  Consider the nature, magnitude, and likelihood of any 
direct benefit to subjects.  If there is no direct benefit to the individual subject, say so here and in 
the consent form (if there is a consent form).  Do not list monetary payment or other 
compensation as a benefit. 
  
 The knowledge gained from this study will provide us a preliminary description of the 
nature of IPV in this community, more importantly, it could guide us to form hypotheses and 
develop programs which will increase the awareness and promote the prevention of IPV among 
this population. 
 
A.4.7.  Full description of risks and measures to minimize risks.  Include risk of psychosocial 
harm (e.g., emotional distress, embarrassment, breach of confidentiality), economic harm (e.g., 
loss of employment or insurability, loss of professional standing or reputation, loss of standing 
within the community) and legal jeopardy (e.g., disclosure of illegal activity or negligence), as 
well as known side effects of study medication, if applicable, and risk of pain and physical 
injury.  Describe what will be done to minimize these risks.  Describe procedures for follow-up, 
when necessary, such as when subjects are found to be in need of medical or psychological 
referral.  If there is no direct interaction with subjects, and risk is limited to breach of 
confidentiality (e.g., for existing data), state this. 
 
  Risk of psychosocial harm to subjects is that subjects may suffer embarrassment if others 
know that they are the victims of IPV.  This factor will be stated in the recruiting letter when we 
look for study participants.  The demographic information that participants provide on the surveys 
may make them identifiable and vulnerable to retaliations from their partners, therefore all survey 
evaluations will be anonymous and voluntary.  The project database will be accessible only to 
those individuals with an identification number and password.  Identification numbers and 
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passwords will be given to individuals who work directly on the project and have a clear need to 
access the data.  Also, the database will be located on a secured server. 
 
A.4.8.  Data monitoring and analysis.  Tell how the qualitative and/or quantitative data will be 
analyzed.  Explain how the sample size is sufficient to achieve the study aims.  This might 
include a formal power calculation or explanation of why a small sample is sufficient (e.g., 
qualitative research, pilot studies). Describe the provisions for monitoring the data to ensure the 
safety of participants.  These plans could range from the investigator monitoring subject data for 
any safety concerns to a sponsor-based DSMB, depending on the study.    
 
We will produce a focus group summary form as soon as possible after each focus group 
has taken place.  This includes practical details about the time and place, the participants, the 
duration of the focus group, and details about the content and emerging themes.  Data will be 
collected in the format of transcripts, written answers on an open-ended questionnaire, or 
notes/memos written by the researcher.  The data analysis will be an on-going process for this 
qualitative pilot study, which means the researcher will think and reflect upon the emerging 
themes, adapting and changing the methods if required.   
Other than analyzing the emerging theme by inductive reasoning (thematic analysis), we 
will also use comparative analysis which compares and contrasts data from different people until 
we are satisfied that no new issues are arising.  Both analysis methods are often used in 
qualitative research studies. 
 
A.4.9.  Will you collect or receive any of the following identifiers?  Does not apply to consent 
forms. 
 
 _X_  No    __  Yes    If yes, check all that apply: 
 
a. __ Names 
b. __ Telephone numbers   
c. __ Any elements of dates (other than year) for dates directly related to an individual, 
including birth date, admission date, discharge date, date of death.  For ages over 89:  all 
elements of dates (including year) indicative of such age, except that such ages and 
elements may be aggregated into a single category of age 90 and older 
d. __ Any geographic subdivisions smaller than a State, including street address, city, county, 
precinct, zip code and their equivalent geocodes, except for the initial three digits of a zip 
code 
e. __ Fax numbers  
f. __ Electronic mail addresses 
g. __ Social security numbers  
h. __ Medical record numbers 
i. __ Health plan beneficiary numbers 
j. __ Account numbers  
k. __ Certificate/license numbers  
l. __ Vehicle identifiers and serial numbers (VIN), including license plate numbers  
m. __ Device identifiers and serial numbers (e.g., implanted medical device) 
n. __ Web universal resource locators (URLs)  
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o. __ Internet protocol (IP) address numbers  
p. __ Biometric identifiers, including finger and voice prints 
q. __ Full face photographic images and any comparable images 
r. __ Any other unique identifying number, code, or characteristic, other than dummy 
identifiers that are not derived from actual identifiers and for which the re-identification key 
is maintained by the health care provider and not disclosed to the researcher 
 
 
A.4.10.  Identifiers in research data.  Are the identifiers in A.4.9 above linked or maintained 
with the research data?   
__  yes  _X_  no 
 
A.4.11.  Confidentiality of the data.  Describe procedures for maintaining confidentiality of the 
data you will collect or will receive.  Describe how you will protect the data from access by 
those not authorized.  How will data be transmitted among research personnel?  Where relevant, 
discuss the potential for deductive disclosure (i.e., directly identifying subjects from a 
combination of indirect IDs). 
 
 All interview/discussion record will be anonymous and will not have any identifying 
information connected.  All consent forms will be held separately from data collected, therefore 
disconnecting data from the participants’ names.  Hard copy records will be stored in a manner 
(for example, locked in file cabinets) that limits access to only authorized individuals.  Electronic 
data will be saved on a device that has the appropriate security safeguards such as unique 
identification of authorized users, password protection, automated operating system 
patch management, anti-virus controls, firewall configuration, and scheduled and automatic 
backups to protect against data loss or theft. 
 
A.4.12.  Data sharing.  With whom will identifiable (contains any of the 18 identifiers listed in 
question A.4.9 above) data be shared outside the immediate research team?  For each, explain 
confidentiality measures.  Include data use agreements, if any. 
 
 _X_  No one 
 __  Coordinating Center:   
 __  Statisticians:   
 __  Consultants:   
 __  Other researchers:   
 __  Registries:   
 __  Sponsors:   
 __  External labs for additional testing:   
 __  Journals:   
 __  Publicly available dataset:   
 __  Other:   
 
A.4.13.  Data security for storage and transmission.  Please check all that apply. 
 
For electronic data stored on a desk top computer: 
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_X_  Secure network     _X_  Password access    __  Data encryption_X_  Password protected 
file(s) 
__  Other comparable safeguard (describe):   
 
For portable computing devices/external storage devices (e.g. laptop computer, PDA, CDs, 
memory sticks): 
_X_  Power-on password   _X_  Automatic log-off    __ Data encryption  _X_  Password 
protected file(s) 
__  Other comparable safeguard (describe):   
 
For hardcopy data (including human biological specimens, CDs, tapes, etc.): 
_X_  Data de-identified by research team (stripped of the 18 identifiers listed in question A.4.9 
above) 
__  Locked suite or office _X_  Locked cabinet 
__  Data coded by research team with a master list secured and kept separately 
__  Other (describe):   
 
A.4.14.  Post-study disposition of identifiable data or human biological materials.  Describe 
your plans for disposition of data or human biological specimens that are identifiable in any way 
(directly or via indirect codes) once the study has ended.  Describe your plan to destroy 
identifiers, if you will do so. 
 
In compliance with “Records Retention and Disposition Schedule, University of North 
Carolina at Chapel Hill, School of Public Health, Department of Epidemiology” as the schedule 
for PH Leadership Program (PHLP) is still under development. 
 
Records concerning grant or internally funded research projects by faculty and/or 
departments/offices including correspondence, project descriptions, final project 
reports/deliverables, patents or inventions, data, and other related records. 
 
Disposition Instructions: 
a. Transfer final project reports/deliverables to the custody of the University Archives 5 
years after termination and final payments, when released from all audits, upon approval 
of the Office of Sponsored Research and after meeting the requirements of the sponsoring 
agency. 
Destroy in office all other related records 5 years after termination and final payments, when 
released from all audits, upon approval of the Office of Sponsored Research, and meeting the 
requirements of the sponsoring agency. 
 
 
 
Part A.5.  The Consent Process and Consent Documentation (including Waivers) 
 
The standard consent process is for all subjects to sign a document containing all the elements of 
informed consent, as specified in the federal regulations.  Some or all of the elements of consent, 
including signatures, may be altered or waived under certain circumstances. 
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 If you will obtain consent in any manner, complete section A.5.1. 
 If you are obtaining consent, but requesting a waiver of the requirement for a signed consent 
document, complete section A.5.2. 
 If you are requesting a waiver of any or all of the elements of consent, complete section 
A.5.3. 
 If you need to access Protected Health Information (PHI) to identify potential subjects who 
will then be contacted, you will need a limited waiver of HIPAA authorization.  This is 
addressed in section B.2. 
 
You may need to complete more than one section.  For example, if you are conducting a phone 
survey with verbal consent, complete sections A.5.1, A.5.2, and possibly A.5.3. 
 
A.5.1.  Describe the process of obtaining informed consent from subjects.  
Describe who will be obtaining consent (or permission) and from whom.  Include discussion, as 
relevant, any waiting period between the initial consent discussion and obtaining consent, and 
steps that will be taken to minimize coercion or undue influence.  If children will be enrolled as 
subjects, describe the provisions for obtaining parental permission and assent of the child.  If 
decisionally impaired adults are to be enrolled, describe the provision for obtaining surrogate 
consent from a legally authorized representative (LAR).  If non-English speaking people will be 
enrolled, explain how consent in the native language will be obtained.  Address both written 
translation of the consent and the availability of oral interpretation.  It is expected that the 
information in the consent document(s) will be communicated to participants or their LAR. After 
you have completed this part A.5.1, if you are not requesting a waiver of any type, you are done 
with Part A.5.; proceed to Part B. 
 Preliminary questions and answers sessions will be held among people who are interested 
in the study and informed consent will be obtained from all of the people who decide to join the 
focus groups.  This includes twelve female Chinese immigrants from the Raleigh/Cary area, 18 
years of age or older (therefore no parental permission is required), married or having been in a 
relationship with a man.  For our study, no non-English speaking women will be enrolled due to 
the limited resources available.  Therefore, we will not address the need for interpretation, 
translations, or LAR services. 
 
A.5.2.  Justification for a waiver of written (i.e., signed) consent.  The default is for subjects to 
sign a written document that contains all the elements of informed consent.  Under limited 
circumstances, the requirement for a signed consent form may be waived by the IRB if either of 
the following is true.  
Choose only one: 
 
a.  The only record linking the subject and the research would be the consent 
document and the principal risk would be potential harm resulting from a 
breach of confidentiality (e.g., study topic is sensitive so that public 
knowledge of participation could be damaging). Participants should be asked 
whether they want documentation linking them with the research and the 
participants’ wishes will govern whether they sign the form.  Note: This 
justification cannot be used in FDA-regulated research.  
__  yes  __  no 
 
 
 
 
 
__  yes  __  no 
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Explain.        
 
b.  The research presents no more than minimal risk of harm to subjects and 
involves no procedures for which written consent is normally required 
outside of the research context (e.g., phone survey). 
Explain.        
 
If you checked “yes” to either (and you are not requesting a waiver in 
section A.5.3) consent must be obtained orally, by delivering a fact sheet, 
through an online consent form, or be incorporated into the survey itself.  
Include a copy of the consent script, fact sheet, online consent form, or 
incorporated document.  
 
→ If you have justified a waiver of written (signed) consent (A.5.2), you should complete 
A.5.3 only if your consent process will not include all the other elements of consent. 
 
A.5.3.  Justification for a full or partial waiver of consent.  The default is for subjects to give 
informed consent.  A waiver might be requested for research involving only existing data or 
human biological specimens (see also Part C).  More rarely, it might be requested when the 
research design requires withholding some study details at the outset (e.g., behavioral research 
involving deception).  In limited circumstances, parental permission may be waived.  This 
section should also be completed for a waiver of HIPAA authorization if research involves 
Protected Health Information (PHI) subject to HIPAA regulation, such as patient records. 
 
 __  Requesting waiver of some elements (specify; see SOP 28 on the IRB web site):   
 __  Requesting waiver of consent entirely 
If you check either of the boxes above, answer items a-f..  To justify a full waiver of the 
requirement for informed consent, you must be able to answer “yes” (or “not applicable” for 
question c) to items a-f.  Insert brief explanations that support your answers. 
 
a.  Will the research involve no greater than minimal risk to subjects or to 
their privacy? 
Explain.   
 
__  yes  __  no 
 
b.  Is it true that the waiver will not adversely affect the rights and welfare of 
subjects?  (Consider the right of privacy and possible risk of breach of 
confidentiality in light of the information you wish to gather.) 
Explain.   
__  yes  __  no 
 
c.  When applicable to your study, do you have plans to provide subjects with 
pertinent information after their participation is over?  (e.g., Will you provide 
details withheld during consent, or tell subjects if you found information with 
direct clinical relevance?  This may be an uncommon scenario.) 
Explain.   
__  yes  __  not 
applicable 
 
 
d.  Would the research be impracticable without the waiver?  (If you checked __  yes  __  no 
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“yes,” explain how the requirement to obtain consent would make the 
research impracticable, e.g., are most of the subjects lost to follow-up or 
deceased?).  Explain.   
 
e.  Is the risk to privacy reasonable in relation to benefits to be gained or the 
importance of the knowledge to be gained? 
Explain.   
__  yes  __  no 
 
If you are accessing patient records for this research, you must also be able to answer “yes” 
to item f to justify a waiver of HIPAA authorization from the subjects. 
 
f.  Would the research be impracticable if you could not record (or use) 
Protected Health Information (PHI)?  (If you checked “yes,” explain how not 
recording or using PHI would make the research impracticable). 
Explain.   
__  yes  __  no 
 
Part B. Questions for Studies that Involve Direct Interaction with Human Subjects 
 →  If this does not apply to your study, do not submit this section. 
 
B.1.  Methods of recruiting.  Describe how and where subjects will be identified and recruited.  
Indicate who will do the recruiting, and tell how subjects will be contacted.  Describe efforts to 
ensure equal access to participation among women and minorities.  Describe how you will 
protect the privacy of potential subjects during recruitment.  For prospective subjects whose 
status (e.g., as patient or client), condition, or contact information is not publicly available (e.g., 
from a phone book or public web site), the initial contact should be made with legitimate 
knowledge of the subjects’ circumstances.  Ideally, the individual with such knowledge should 
seek prospective subjects’ permission to release names to the PI for recruitment.  Alternatively, 
the knowledgeable individual could provide information about the study, including contact 
information for the investigator, so that interested prospective subjects can contact the 
investigator.  Provide the IRB with a copy of any document or script that will be used to obtain 
the patients’ permission for release of names or to introduce the study.  Check with the IRB for 
further guidance. 
 Investigators will collaborate with the Triangle Area Chinese American Society 
(TACAS) to recruit the subjects.  TACAS is dedicated to community services and co-organizes 
various local events such as Asian American Health Fair and immigration seminars.  We will 
distribute flyers during TACAS events; advertise on the TACAS Newsletter and website.  We 
will also give pamphlets and flyers at Grand Asia Market which is located at Cary and is visited 
by numerous Chinese in the area.   
 Questions and answers sessions will be held for interested people and they will be invited 
to the study.  However, they will become study participants only after they sign the written 
consent. 
 
B.2.  Protected Health Information (PHI).  If you need to access Protected Health Information 
(PHI) to identify potential subjects who will then be contacted, you will need a limited waiver of 
HIPAA authorization.  If this applies to your study, please provide the following information and 
complete Section C. 
 29 
 
a. Under this limited waiver, you are allowed to access and use only the minimum amount of 
PHI necessary to review eligibility criteria and contact potential subjects.  What information 
are you planning to collect for this purpose?  
 
b. How will confidentiality/privacy be protected prior to ascertaining desire to participate?   
 
c. When and how will you destroy the contact information if an individual declines 
participation?   
 
 
B.3.  Duration of entire study and duration of an individual subject’s participation, 
including follow-up evaluation if applicable.  Include the number of required contacts and 
approximate duration of each contact. 
   The duration of the whole study is one month and two meetings will be held for each 
focus group.  The first meeting will last 60 minutes; the second meeting will last 45 minutes 
followed by a 15 minute post-class evaluation survey.   
 
B.4.  Where will the subjects be studied?  Describe locations where subjects will be studied, 
both on and off the UNC-CH campus. 
 All meetings will be held at InterAct Family Safety & Empowerment Center, 1012 
Oberline Road, Raleigh, NC  27605 
 
B.5.  Privacy.  Describe procedures that will ensure privacy of the subjects in this study.  
Examples include the setting for interviews, phone conversations, or physical examinations; 
communication methods or mailed materials (e.g., mailings should not indicate disease status or 
focus of study on the envelope). 
 Subjects will be assigned a coded number when they sign up on a class roster or when 
they complete a survey for the program.  Therefore, only the demographics associated with the 
subject, not their name, will be used for data analysis.  All documents containing name and 
contact information of the participants will be kept in a locked cabinet that will be accessible 
only to the principal investigator (Huei-Chen Lao) and Ms. Kaur.  Information will then be 
entered into a database by the principal investigator which will be password protected.  This will 
also be only accessible to the principal investigator and Ms. Kaur.  No program materials will be 
mailed to the home of program subjects. 
 
B.6.  Inducements for participation.  Describe all inducements to participate, monetary or non-
monetary.  If monetary, specify the amount and schedule for payments and if/how this will be 
prorated if the subject withdraws (or is withdrawn) from the study prior to completing it.  For 
compensation in foreign currency, provide a US$ equivalent.  Provide evidence that the amount 
is not coercive (e.g., describe purchasing power for foreign countries).  Be aware that payment 
over a certain amount may require the collection of the subjects’ Social Security Numbers.  If a 
subject is paid more than $200.00 per year, collection of subjects’ Social Security Number is 
required (University policy—see SSN Guidance) using  the Social Security Number collection 
consent addendum found under forms on the IRB website (look for Study Subject 
Reimbursement Form). 
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 No monetary inducement will be provided.  A reception will be held after the second 
meeting and each participant will be given a bag of gifts which is valued no more than $10.00. 
 
B.7.  Costs to be borne by subjects.  Include child care, travel, parking, clinic fees, diagnostic 
and laboratory studies, drugs, devices, all professional fees, etc.  If there are no costs to subjects 
other than their time to participate, indicate this. 
 
Costs to the program participants will be kept to a minimum.  Costs incurred to 
participants include their time and some travel expenses to InterAct which is centrally located in 
Raleigh. Child care services during the group sessions will be provided by InterAct staff 
members.  
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